Homocysteine research – where do we stand and where are we going?

Articles in the same Issue

1. Homocysteine research – where do we stand and where are we going?
2. Hyperhomocysteinemia and arteriosclerosis: historical perspectives
3. Homocysteine and heart failure: a review of investigations from the Framingham Heart Study
4. Homocysteine and vascular disease in diabetes: a double hit?
5. Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia
6. Effects of homocysteine on vascular and tissue adenosine: a stake in homocysteine pathogenicity?
7. Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease
8. Carotid narrowing degree and plasma thiol levels in carotid endarterectomy patients
9. Impairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy
10. Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation
11. Hyperhomocysteinemia and macromolecule modifications in uremic patients
12. Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients
13. Vitamin B₁₂ deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population
14. Homocysteine, folic acid and vitamin B₁₂ in relation to pre- and postnatal health aspects
15. Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration project
16. A laboratory algorithm with homocysteine as the primary parameter reduces the cost of investigation of folate and cobalamin deficiency
17. Betaine: a key modulator of one-carbon metabolism and homocysteine status
18. Molecular targeting by homocysteine: a mechanism for vascular pathogenesis
19. Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro
20. Homocysteine in relation to cognitive performance in pathological and non-pathological conditions
21. Homocysteine and B vitamins in mild cognitive impairment and dementia
22. Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study
23. Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions
24. Homocysteine – a newly recognised risk factor for osteoporosis
25. Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women
26. Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
27. Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance
28. Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status
29. Asymmetric dimethylarginine, homocysteine and renal function – is there a relation?
30. Interactions between folate and aging for carcinogenesis
31. The potential cocarcinogenic effect of vitamin B₁₂ deficiency
32. The vegetarian lifestyle and DNA methylation